0001019056-20-000244.txt : 20200319
0001019056-20-000244.hdr.sgml : 20200319
20200319183507
ACCESSION NUMBER: 0001019056-20-000244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200218
FILED AS OF DATE: 20200319
DATE AS OF CHANGE: 20200319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Marvin L
CENTRAL INDEX KEY: 0001493324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 20729781
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
white.xml
X0306
4
2020-02-18
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001493324
White Marvin L
2401 4TH AVENUE
SUITE 1050
SEATTLE
WA
98121
1
1
0
0
President and CEO
Stock Option (right to buy)
0.498
2020-02-18
4
A
0
303200
0
A
2030-02-17
Common Stock
303200
303200
D
The option vests in three approximately equal annual installments beginning on February 17, 2021.
/s/ Carl A. Valenstein, attorney-in-fact
2020-03-19